Abstract |
Streptozotocin is a natural product that selectively kills insulin-secreting beta cells, and is widely used to generate mouse models of diabetes or treat pancreatic tumors. Several studies suggest that streptozotocin toxicity stems from its N-nitrosourea moiety releasing nitric oxide and possessing DNA alkylating activity. However, it has also been proposed that streptozotocin induces apoptosis by inhibiting O-GlcNAcase, an enzyme that, together with O-GlcNAc transferase, is important for dynamic intracellular protein O-glycosylation. We have used galacto- streptozotocin to chemically dissect the link between O-GlcNAcase inhibition and apoptosis. Using X-ray crystallography, enzymology, and cell biological studies on an insulinoma cell line, we show that, whereas streptozotocin competitively inhibits O-GlcNAcase and induces apoptosis, its galacto-configured derivative no longer inhibits O-GlcNAcase, yet still induces apoptosis. This supports a general chemical poison mode of action for streptozotocin, suggesting the need for using more specific inhibitors to study protein O-GlcNAcylation.
|
Authors | Shalini Pathak, Helge C Dorfmueller, Vladimir S Borodkin, Daan M F van Aalten |
Journal | Chemistry & biology
(Chem Biol)
Vol. 15
Issue 8
Pg. 799-807
(Aug 25 2008)
ISSN: 1074-5521 [Print] United States |
PMID | 18721751
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Streptozocin
- hexosaminidase C
- beta-N-Acetylhexosaminidases
- Acetylglucosamine
|
Topics |
- Acetylglucosamine
(metabolism)
- Animals
- Antineoplastic Agents
(chemistry, metabolism, pharmacology)
- Apoptosis
(drug effects)
- Binding, Competitive
- Cell Death
(drug effects)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Insulin-Secreting Cells
(cytology, drug effects)
- Insulinoma
(pathology)
- Mice
- Streptozocin
(chemistry, metabolism, pharmacology)
- beta-N-Acetylhexosaminidases
(antagonists & inhibitors, chemistry, metabolism)
|